1887

Abstract

By using a focus reduction assay in CrFK feline fibroblast cells, virus neutralizing antibodies (VNA) to feline immunodeficiency virus (FIV) were demonstrated in cats that had been naturally or experimentally infected with FIV. The antigenic relatedness of four strains of FIV, divergent in nucleotide sequence within the gene, was investigated by neutralization following adaptation of each virus for growth in CrFK cells. Two of the viruses were from The Netherlands (FIV/AM-4 and AM-6), one was from the U.K. (FIV/GL-8) and one was from the U.S.A. (FIV/PET). Reaction of the viruses in the neutralization assay with cat antibodies to homologous or heterologous strains indicated that while there was a degree of cross-reactivity between all four, there were consistent differences suggesting the existence of FIV neutralization subtypes. In particular, FIV/PET and FIV/AM-6 were closely related but FIV/PET and FIV/GL-8 were clearly distinct. VNA from naturally infected cats in the field showed a pattern of reactivity against FIV/PET and FIV/GL-8 that confirmed the antigenic diversity of FIV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-12-3641
1994-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/12/JV0750123641.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-12-3641&mimeType=html&fmt=ahah

References

  1. Callanan J., Hosie M. I., Jarrett O. 1991; Transmission of FIV from mother to kitten. Veterinary Record 128:332–333
    [Google Scholar]
  2. Cheng-Mayer C., Homsy J., Evans L. A., Levy J. A. 1988; Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proceedings of the National Academy of Sciences, U.S.A 85:2815–2819
    [Google Scholar]
  3. de Ronde A., Stam J. G., Boers P., Langedijk H., Meloen R., Hesselink W., Keldermans L. C., Van Vliet A., Verschoor E. J., Horzinek M. C. 1994; Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:257–264
    [Google Scholar]
  4. Fevereiro M., Roneker C., Laufs A., Tavares L., de Noronha F. 1991; Characterization of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity. Journal of General Virology 72:617–622
    [Google Scholar]
  5. Fiosie M. J., Jarrett O. 1990; Serological responses of cats to feline immunodeficiency virus. AIDS 4:215–220
    [Google Scholar]
  6. Mckeating J. A., Shotton C., Cordell J., Graham S., Balfe P., Sullivan N., Charles M., Page M., Bolmstedt A., Olofsson S., Kayman C., Wu Z., Pinter A., Dean C., Sodroski J., Weiss R. A. 1993; Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. Journal of Virology 67:4932–4944
    [Google Scholar]
  7. Pancino G., Chappey C., Saurin W., Sonigo P. 1993; B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. Journal of Virology 67:664–672
    [Google Scholar]
  8. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. 1987; Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790–793
    [Google Scholar]
  9. Reid G., Rigby M., Mcdonald M., Hosie M., Neil J. C., Jarrett O. 1991; Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS 5:1477–1483
    [Google Scholar]
  10. Rigby M. A., Holmes E. C., Pistello M., Mackay A., Leighbrown A. J., Neil J. C. 1993; Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. Journal of Virology 74:425–436
    [Google Scholar]
  11. Siebelink K. H. J., Rimmelzwaan G. F., Bosch M. L., Meloen R. H., Osterhaus A. D. M. E. 1993; A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. Journal of Virology 67:2202–2208
    [Google Scholar]
  12. Siebelink K. H. J., Karlas J. A., Rimmelzwaan G. F., Osterhaus A. D. M. E., Bosch M. L. 1994; A determinant of feline immunodeficiency virus involved in CrFK cell tropism. Veterinary Immunology and Immunopathology in press
    [Google Scholar]
  13. Sodora D. L., Shpaer E. G., Kitchell B. E., Dow S. W., Hoover E. A., Mullins J. I. 1994; Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. Journal of Virology 68:2230–2238
    [Google Scholar]
  14. Tozzini F., Matteucci D., Bandecchi P., Baldinotti F., Poli A., Pistello M., Siebelink K. H. J., Ceccherini-Nelli L., Bendinelli M. 1992; Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. Journal of Virological Methods 37:241–252
    [Google Scholar]
  15. Tozzini F., Matteucci D., Bandecchi P., Baldinotti F., Siebelink K., Osterhaus A., Bendinelli M. 1993; Neutralizing antibodies in cats infected with feline immunodeficiency virus. Journal of Clinical Microbiology 31:1626–1629
    [Google Scholar]
  16. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. 1986; Variable and conserved neutralization antigens of human immunodeficiency virus. Nature; London: 324572–575
    [Google Scholar]
  17. Yamamoto J. K., Okuda T., Ackley C. D., Louie H., Pembroke E., Zochlinski H., Munn R. J., Gardner M. B. 1991; Experimental vaccine protection against feline immunodeficiency virus. AIDS Research and Human Retroviruses 7:911–921
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-12-3641
Loading
/content/journal/jgv/10.1099/0022-1317-75-12-3641
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error